Legal Representation
Attorney
Robert L. Powley
USPTO Deadlines
Next Deadline
166 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 26, 2025
Extension Available
Until December 26, 2024
Application History
24 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 28, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Mar 27, 2025 | EXT3 | S | SOU EXTENSION 3 FILED |
| Mar 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 14, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Nov 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 14, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 6, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 6, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 31, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 31, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 11, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 28, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 27, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 27, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 27, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Sep 27, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Aug 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 10, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 22, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 040
Custom manufacture of pharmaceuticals by pharmaceutical compounders
Class 042
Consultancy pertaining to pharmacology; Pharmaceutical research and development services; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Pharmaceutical drug development services
Class 044
Pharmaceutical compounding services
Additional Information
Translation
The wording "NANOMI" has no meaning in a foreign language.
Classification
International Classes
040
042
044
USPTO Documents
Loading USPTO documents...